CASI Pharmaceuticals: Q1 Earnings Insights

CASI Pharmaceuticals CASI reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

CASI Pharmaceuticals beat estimated earnings by 33.33%, reporting an EPS of $-0.06 versus an estimate of $-0.09.

Revenue was up $3.33 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 1.9% increase in the share price the next day.

Here's a look at CASI Pharmaceuticals's past performance:

To track all earnings releases for CASI Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.